The downgrade to Equal-Weight suggests that Morgan Stanley sees limited upside potential for SPG, aligning it with market performance expectations. However, the increase in the price target to $143 indicates a belief that the stock still has room to grow, albeit at a pace that is consistent with the market. This mixed signal could lead to a neutral short-term impact on the stock price as investors digest both the downgrade and the increased price target.